Compass Therapeutics, Inc. CMPX 深 沪
等待开盘 10-07 09:30:00 美东时间
0.9767
+0.016
+1.68%
华盛通- 最 高2.55
- 今 开0.99
- 成交量 388.41万股
- 最 低 0.8294
- 昨 收 0.9606
- 总市值 9.86万
- 52周最高 6.88
- 市盈率 静 --
- 换手率 3845.61%
- 52周最低 0.8294
- 委 比 -81.82%
- 总股本 0.00亿
- 历史最高 11.91
- 量 比 0.68
- 振 幅 179.12%
- 历史最低 0.765
- 每 手 1
- 风险率 1.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Compass Therapeutics Craters, FDA Pushes Survival-Trial Demand for Cancer Drug
Compass Therapeutics shares plunge after FDA seeks a survival-benefit trial before tovecimig’s FDA marketing application.
09-23 02:02
Dow Gains Over 100 Points; AutoZone Posts Upbeat Earnings
U.S. stocks rose Tuesday: Dow +0.24%, Nasdaq +0.39%, S&P 500 +0.18%. Communication services led; energy fell. AutoZone beat earnings; oil dropped 2.4%.
09-22 21:43
Compass Therapeutics Q1 EPS $(0.10), Inline
Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last
05-05 19:52
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
Compass Therapeutics will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, from 11:05 to 11:35 AM ET. More details and a webcast link are available.
2025-05-28 12:00
Ladenburg Thalmann Upgrades Compass Therapeutics to Buy, Announces $5 Price Target
Ladenburg Thalmann analyst Aydin Huseynov upgrades Compass Therapeutics (NASDAQ:CMPX) from Neutral to Buy and announces $5 price target.
2024-09-16 21:26
